ERBB2 and breast carcinoma: By analyzing the number of NK cells that adhered to breast cancer cells, we found that Herceptin enhanced the adhesion of Herceptin-treated NK cells with HER2+ cells but not HER2− cells, within 20 min of coculture (Figure 3B).